What the company does
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinformatics, and 2D and 3D histology with artificial intelligence pathology. It also has a portfolio strategy of potential drug candidates in the form of upfront payments, research …
What the weekly tape is saying
GUBRA closed the latest completed week at 361.4 DKK. The 4-week return is 10.9% and the 12-week return is -4.5%. Trend Signal is inactive, Market Dynamics is 0.16. Setup signature: Deep recovery attempt with a 41/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 407.2 DKK
- Vs Trend Line
- -11.3%
- Fair Value
- 343.2 DKK
- Vs Fair Value
- 5.3%
- 52W High
- 557.5 DKK
- 52W Low
- 293.0 DKK
- Drawdown
- -35.2%
- Range Position
- 25.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 19
- 52W Active Breadth
- 36.5%
- Sector Scope
- DK Healthcare
- Sector Rank
- 4 of 21
- Sector Percentile
- 85.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DK Healthcare
- Tracked Peers
- 21
- 4W Rank
- 3 of 21
- Avg 1W
- -0.6%
- Avg 4W
- 1.9%
- Trend Breadth
- 28.6%
- Positive MD
- 66.7%
DK Biotechnology
- Tracked Peers
- 7
- 4W Rank
- 1 of 7
- Avg 1W
- -0.5%
- Avg 4W
- -2.1%
- Trend Breadth
- 14.3%
- Positive RS
- 14.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.16
- 4W MD Change
- 115.1%
- Relative Strength
- -12.66
- 4W RS Change
- 41.5%
- Expectation
- Undecided
- Probability
- 50.35%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 252.3K
- 13W Average
- 141.6K
- 52W Average
- 165.3K
- Vs 13W
- 1.8x
- Vs 52W
- 1.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.7%
- 52W Volatility
- 6.3%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 4.8% / -4.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- CPH
- Country
- DK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- DKK
- Market Cap
- 5.5B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 361.4 DKK | 1.7% | 407.2 DKK | 343.2 DKK | 0.16 | -12.66 | 252.3K | Off |
| 5 Jun 2026 | 355.2 DKK | -0.6% | 410.1 DKK | 341.5 DKK | -0.28 | -13.87 | 123.4K | Off |
| 29 May 2026 | 357.4 DKK | 5.1% | 411.0 DKK | 339.7 DKK | -0.53 | -14.93 | 156.8K | Off |
| 22 May 2026 | 340.0 DKK | 4.3% | 413.4 DKK | 338.0 DKK | -0.85 | -19.08 | 136.7K | Off |
| 15 May 2026 | 326.0 DKK | 0.8% | 415.8 DKK | 336.4 DKK | -1.04 | -21.63 | 120.2K | Off |
| 8 May 2026 | 323.4 DKK | 0.7% | 418.4 DKK | 334.8 DKK | -1.05 | -21.35 | 166.8K | Off |
| 1 May 2026 | 321.0 DKK | 0.5% | 422.0 DKK | 333.3 DKK | -1.13 | -22.42 | 152.4K | Off |
| 24 Apr 2026 | 319.4 DKK | -10.8% | 426.3 DKK | 331.9 DKK | -1.16 | -22.12 | 136.3K | Off |
| 17 Apr 2026 | 358.0 DKK | 5.0% | 428.4 DKK | 330.4 DKK | -1.19 | -15.40 | 168.8K | Off |
| 10 Apr 2026 | 340.8 DKK | -6.4% | 430.7 DKK | 328.7 DKK | -1.23 | -18.04 | 136.1K | Off |
| 3 Apr 2026 | 364.2 DKK | 2.5% | 431.9 DKK | 327.2 DKK | -1.15 | -10.27 | 90.7K | Off |
| 27 Mar 2026 | 355.4 DKK | -6.1% | 433.0 DKK | 325.5 DKK | -1.08 | -8.63 | 67.0K | Off |
| 20 Mar 2026 | 378.4 DKK | 2.6% | 433.6 DKK | 325.3 DKK | -0.94 | -1.91 | 133.2K | Off |
| 13 Mar 2026 | 368.8 DKK | -1.7% | 433.4 DKK | 324.9 DKK | -0.95 | -7.06 | 228.4K | Off |